Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Vistagen Therapeutics, Inc. | VP, CFO | Common Stock | 3.67K | $6.3K | $1.72 | Jun 30, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
VTGN | Vistagen Therapeutics, Inc. | Jun 30, 2023 | 1 | $265 | 4 | Jul 5, 2023 | VP, CFO |
VTGN | VistaGen Therapeutics, Inc. | Dec 30, 2022 | 1 | $438 | 4 | Jan 3, 2023 | VP, CFO AND SECRETARY |
VTGN | VistaGen Therapeutics, Inc. | Jun 30, 2022 | 1 | $3.74K | 4 | Jul 15, 2022 | VP, CFO AND SECRETARY |
VTGN | VistaGen Therapeutics, Inc. | Mar 1, 2022 | 1 | $0 | 4 | Mar 3, 2022 | VP, CFO AND SECRETARY |
VTGN | VistaGen Therapeutics, Inc. | Jan 11, 2022 | 2 | $18.8K | 4 | Jan 12, 2022 | VP, CFO AND SECRETARY |
VTGN | VistaGen Therapeutics, Inc. | Dec 31, 2021 | 1 | $5.93K | 4 | Jan 3, 2022 | VP, CFO AND SECRETARY |
VTGN | VistaGen Therapeutics, Inc. | Sep 7, 2021 | 1 | -$93.8K | 4 | Sep 8, 2021 | VP, CFO AND SECRETARY |
VTGN | VistaGen Therapeutics, Inc. | Jun 30, 2021 | 8 | $90.3K | 4 | Jul 2, 2021 | VP, CFO AND SECRETARY |